Page last updated: 2024-08-25

rosiglitazone and Fetal Death

rosiglitazone has been researched along with Fetal Death in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bo, QL; Chen, YH; Fu, L; Wang, H; Xu, DX; Yu, Z; Zhang, GB; Zhang, ZH; Zhou, Y	1

Other Studies

1 other study(ies) available for rosiglitazone and Fetal Death

Article	Year
Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation. Molecular and cellular endocrinology, 2016, Mar-05, Volume: 423 Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Chemokines; Drug Evaluation, Preclinical; Female; Fetal Death; Lipopolysaccharides; Male; Mice, Inbred ICR; NF-kappa B; Placenta; PPAR gamma; Pregnancy; Rosiglitazone; Signal Transduction; Thiazolidinediones	2016

Article

Year

Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation.

Molecular and cellular endocrinology, 2016, Mar-05, Volume: 423

Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Chemokines; Drug Evaluation, Preclinical; Female; Fetal Death; Lipopolysaccharides; Male; Mice, Inbred ICR; NF-kappa B; Placenta; PPAR gamma; Pregnancy; Rosiglitazone; Signal Transduction; Thiazolidinediones

2016